Sloane B F, Honn K V
Cancer Metastasis Rev. 1984;3(3):249-63. doi: 10.1007/BF00048388.
Cysteine proteinases are a subclass of endopeptidases which require activation by thiol reagents. A tumor cysteine proteinase which appears to be related to lysosomal cathepsin B has been implicated in the ability of tumor cells to invade the extracellular matrix and to metastasize to secondary sites. Lysosomal cathepsin B can degrade such components of the extracellular matrix as collagen, fibronectin and proteoglycans. Activity of this cathepsin B-like cysteine proteinase (CB) has been correlated with tumor malignancy in a number of tumor lines yet not in all tumor lines studied. CB activity in tumors seems to be associated with the viable tumor cells, probably with the plasma membrane of these tumor cells. CB activity has been measured in the sera, urine, ascites fluid and pancreatic fluid of tumor-bearing patients. CB is released from tumor explants and tumor cells in vitro as well as from normal subcutaneous tissue exposed to tumor-conditioned medium. Cathepsin B from normal tissues is rapidly inactivated above pH 7.0. Therefore, CB in tumor cell membranes or released from tumor cells (or from host cells in response to tumor cells) may not possess proteolytic activity at neutral pH and thus may not facilitate tumor cell invasion. However, CB exhibits enhanced stability at neutral or slightly alkaline pH's. There is not yet definitive proof that CB plays a role in tumor invasion and metastasis. There is, however, an increasing body of correlative evidence relating CB activity and tumor malignancy. This correlative evidence plus preliminary evidence that tumor CB can degrade components of the extracellular matrix in vitro suggests that CB may be one proteinase active in a proteolytic cascade resulting in tumor invasion and metastasis.
半胱氨酸蛋白酶是一类内肽酶,需要巯基试剂激活。一种似乎与溶酶体组织蛋白酶B相关的肿瘤半胱氨酸蛋白酶,与肿瘤细胞侵入细胞外基质并转移至继发部位的能力有关。溶酶体组织蛋白酶B能降解细胞外基质的成分,如胶原蛋白、纤连蛋白和蛋白聚糖。在许多肿瘤细胞系中,这种类组织蛋白酶B的半胱氨酸蛋白酶(CB)活性与肿瘤恶性程度相关,但并非在所有研究的肿瘤细胞系中都如此。肿瘤中的CB活性似乎与存活的肿瘤细胞有关,可能与这些肿瘤细胞的质膜有关。已对荷瘤患者的血清、尿液、腹水和胰液中的CB活性进行了测定。CB可在体外从肿瘤外植体和肿瘤细胞中释放出来,也可从暴露于肿瘤条件培养基的正常皮下组织中释放出来。正常组织中的组织蛋白酶B在pH 7.0以上会迅速失活。因此,肿瘤细胞膜中的CB或从肿瘤细胞(或宿主细胞对肿瘤细胞的反应)释放的CB在中性pH下可能不具有蛋白水解活性,因此可能不会促进肿瘤细胞的侵袭。然而,CB在中性或略碱性pH下表现出增强的稳定性。尚无确凿证据表明CB在肿瘤侵袭和转移中起作用。然而,越来越多的相关证据将CB活性与肿瘤恶性程度联系起来。这些相关证据加上肿瘤CB可在体外降解细胞外基质成分的初步证据表明,CB可能是参与导致肿瘤侵袭和转移的蛋白水解级联反应的一种蛋白酶。